Agah Ramtin bought 50,000 shares of RenovoRx, Inc. at $0.93 for $46.5k on Nov 16, 2026

Buy
Form 4 code P. Open-market or private purchase of a non-derivative or derivative security.
Executive Chairman and CMO
Executive Chairman and CMO
Filed Nov 17, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$46,485Shares × reported price
Shares traded
50,000Common Stock
Price per share
$0.93Reported price. Read footnotes for ranges.
% of reported position traded
6.26%This security and ownership context
Holdings after
848,460Direct
Trade date
Nov 16, 2026Buy
Filed
Nov 17, 2026, 6:30 AM ET1-day reporting delay
Accession
0001493152-26-052696Code P · Transaction 402467
How reported position traded is calculated

Shares purchased ÷ (holdings after − shares purchased). Estimated position before: 798,460 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

RNXT price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
RNXT · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 24, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago −14%1w ago 0%1d ago 0%
Returns since7d30d90d180d1y

Footnotes in full

F1: Reflects open market purchases of the Issuer's securities. F2: Reflects a weighted average price. The securities were purchased in multiple transactions at per share prices ranging from $0.925 to $0.9299.